Toll‐like receptors and NLRP3 as central regulators of pancreatic islet inflammation in type 2 diabetes-Reference-Cited by-同舟云学术

Toll‐like receptors and NLRP3 as central regulators of pancreatic islet inflammation in type 2 diabetes

Published:2014-02-04 Issue:4 Volume:92 Page:314-323
ISSN:0818-9641
Container-title:Immunology & Cell Biology
language:en
Short-container-title:Immunol Cell Biol

Author:

Westwell‐Roper Clara¹,Nackiewicz Dominika²,Dan Meixia²,Ehses Jan A²

Affiliation:

1. Department of Pathology and Laboratory Medicine, Faculty of Medicine, The University of British Columbia, Child and Family Research InstituteVancouverBritish ColumbiaCanada

2. Department of Surgery, Faculty of Medicine, The University of British Columbia, Child and Family Research InstituteVancouverBritish ColumbiaCanada

Funder

Child and Family Research Institute

University of British Columbia

Canadian Diabetes Association

Publisher

Wiley

Subject

Cell Biology,Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1038/icb.2014.4

Reference131 articles.

1. The beta cell lesion in type 2 diabetes: there has to be a primary functional abnormality

2. Islet growth and development in the adult

3. Mechanisms linking obesity to insulin resistance and type 2 diabetes

4. Five Stages of Evolving Beta-Cell Dysfunction During Progression to Diabetes

5. Islet cell failure in type 2 diabetes

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gut dysbiosis promotes islet-autoimmunity by increasing T-cell attraction in islets via CXCL10 chemokine;Journal of Autoimmunity;2023-11

2. Enteroviral infections are not associated with type 2 diabetes;Frontiers in Endocrinology;2023-10-30

3. Sodium Glucose Transporter-2 Inhibitors (SGLT2Is)-TLRs Axis Modulates Diabetes;Cell Biochemistry and Biophysics;2023-09-01

4. Microbiota and Glucidic Metabolism: A Link with Multiple Aspects and Perspectives;International Journal of Molecular Sciences;2023-06-20

5. Insights on the NF-κB system in polycystic ovary syndrome, attractive therapeutic targets;Molecular and Cellular Biochemistry;2023-04-25